Hans Kaspar Binz
28Patents
8h-index
36Co-inventors
75Inventor score
Filing activity: Jan 6, 1995 → Aug 12, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7417130B2 | Collection of repeat proteins comprising repeat modules | Chemistry; Metallurgy | 40 | Expired |
| US6149911A | Method for enhancing the immunogenicity of an immunogenic compound or hapten, and use thereof for preparing vaccines | Chemistry; Metallurgy | 38 | Expired |
| US8710187B2 | Modified binding proteins inhibiting the VEGF-A receptor interaction | Chemistry; Metallurgy | 20 | Active |
| US6113911A | Peptide fragment of respiratory syncytial virus protein G, immunogenic agent, pharmaceutical composition containing it and preparation method | Chemistry; Metallurgy | 19 | Expired |
| US9458211B1 | Recombinant proteins that simultaneously bind HGF, VEGF-A and serum albumin, comprising ankyrin repeat domains | Chemistry; Metallurgy | 16 | Active |
| US9006389B2 | Repeat protein from collection of repeat proteins comprising repeat modules | Chemistry; Metallurgy | 9 | Active |
| US7220545B2 | Peptide fragment of respiratory syncytial virus protein G, immunogenic agent, pharmaceutical composition containing it and preparation method | Chemistry; Metallurgy | 8 | Expired |
| US9284361B2 | Designed repeat proteins binding to serum albumin | Chemistry; Metallurgy | 8 | Active |
| US9221892B2 | Capping modules for designed ankyrin repeat proteins | Chemistry; Metallurgy | 7 | Active |
| US6130091A | Method for obtaining a peptide derived from the respiratory syncytial virus polypeptide and bacterium expressing it | Emerging Cross-Sectional Technologies | 6 | Expired |
| US10646542B2 | Modified binding proteins inhibiting the VEGF-A receptor interaction | Chemistry; Metallurgy | 5 | Active |
| US6410030B1 | Peptide fragment of respiratory syncytial virus protein G, immunogenic agent, pharmaceutical composition containing it and preparation process | Chemistry; Metallurgy | 4 | Expired |
| US6537556B1 | Peptide fragment of respiratory syncytial virus protein G, immunogenic agent, pharmaceutical composition containing it and preparation process | Chemistry; Metallurgy | 3 | Expired |
| US9289466B2 | Modified binding proteins inhibiting the VEGF-A receptor interaction | Chemistry; Metallurgy | 2 | Active |
| US5601799A | Partially delipidated D25 polysaccaride composition for imaging and diagnosis | Human Necessities | 2 | Expired |
| US9775912B2 | Designed repeat proteins binding to serum albumin | Chemistry; Metallurgy | 2 | Active |
| US6197929A | Carrier protein having an adjuvant effect, immunogenic complex containing it, process for their preparation, nucleotide sequence and vaccine | Emerging Cross-Sectional Technologies | 2 | Expired |
| US6616930B2 | Peptide fragment of respiratory syncytial virus protein G, immunogenic agent, pharmaceutical composition containing it and preparation method | Chemistry; Metallurgy | 1 | Expired |
| US11578427B2 | Designed ankyrin repeat domains with altered surface residues | Emerging Cross-Sectional Technologies | 1 | Active |
| US9849158B2 | Modified binding proteins inhibiting the VEGF-A receptor interaction | Chemistry; Metallurgy | 1 | Active |
| US11332501B2 | Recombinant binding proteins and their use | Chemistry; Metallurgy | 0 | Active |
| US6780420B1 | Carrier protein having an adjuvant effect, immunogenic complex containing it, process for their preparation, nucleotide sequence and vaccine | Emerging Cross-Sectional Technologies | 0 | Expired |
| US10155791B2 | Recombinant binding proteins and their use | Chemistry; Metallurgy | 0 | Active |
| US10322190B2 | Capping modules for designed ankyrin repeat proteins | Chemistry; Metallurgy | 0 | Active |
| US7408044B2 | Carrier protein having an adjuvant effect | Emerging Cross-Sectional Technologies | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.